News Archive
Nematode Trial Data Update
Eden is pleased to report the first results of its trials programme conducted by Anadiag S.R.L in Southern Europe looking at control of nematodes in protected vegetable crops.
Following on from previous product screening trials in 2008 which identified two leading candidates, a series of trials were set up at the end of 2008 in glasshouse tomato crops. The leading Eden encapsulated terpene product gave 83% control of root knot nematode. To put this into perspective, the conventional nematicide standard "Vydate" gave only 50% control.
Further trials results are expected in the coming months and full scale registration trials will continue later in 2009.
For trial data results please visit http://www.edenresearch.co.uk/html/products/trial-data/
Tim Griffiths the Chief Executive of Eden Research plc said:-
"These results are very good news for the Eden. The global hunt for new solutions to replace older toxic nematicides and soil sterilants is intense. As regulators place further restrictions on existing products, growers still face potential devastation of their crops by soil-inhabiting nematodes.
With an approximately $1 billion market for nematicides and sterilants to be replaced, the rewards are high for companies that can offer safer and effective technologies. Eden will now continue into the second year of field testing as part of its registration programme."
For further information:
Tim Griffiths, Chief Executive
Eden Research plc
Tel: 01993 868844
ABOUT EDEN RESEARCH PLC
Eden Research plc is a UK publicly listed company on the PLUS Market, specialising in the development of agrochemical products and intellectual property through licensing and marketing agreements.
Eden is focused on developing products for the agricultural sector through the application of terpene chemistry and other patented environmentally friendly technologies. Eden is currently working alongside universities and partner companies in developing its product portfolio towards commercialisation.
For further information please visit www.edenresearch.com.